Schedule 13D ownership disclosure

CARTESIAN THERAPEUTICS INC

Security class unavailable · CUSIP: 816212104

Event date: 2020-10-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
18,404,586
Percent of class
17.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-031392
Form type
SC 13D/A
Filer
Cartesian Therapeutics, Inc.
CIK
CIK 1453687
Filed
Oct 15, 2020
Reporting period
Oct 06, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub